0001193125-11-175875 Sample Contracts

BIOCRYST PHARMACEUTICALS, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement

At Market Issuance Sales Agreement • June 28th, 2011 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  At Market Issuance Sales Agreement
• Filed
  June 28th, 2011
• Company
  Biocryst Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: